PriceTargets.com logo

NeueHealth - NEUE Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $8.00
  • Forecasted Upside: 30.93%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.11 As of 04/26/2024 01:00 AM ET
▼ -0.22 (-3.48%)

This chart shows the closing price for NEUE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NeueHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NEUE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NEUE

Analyst Price Target is $8.00
▲ +30.93% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for NeueHealth in the last 3 months. The average price target is $8.00, with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 30.93% upside from the last price of $6.11.

This chart shows the closing price for NEUE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 investment analysts is to hold stock in NeueHealth. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/28/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/13/2024Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$7.00 ➝ $8.00N/A
(Data available from 4/28/2019 forward)

News Sentiment Rating

0.01 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/28/2024
  • 7 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/29/2024
  • 0 very positive mentions
  • 31 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
4/28/2024

Current Sentiment

  • 0 very positive mentions
  • 31 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
NeueHealth logo
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Read More

Today's Range

Now: $6.11
Low: $5.95
High: $6.48

50 Day Range

MA: $7.03
Low: $5.82
High: $10.10

52 Week Range

Now: $6.11
Low: $4.94
High: $37.20

Volume

15,815 shs

Average Volume

4,329 shs

Market Capitalization

$50.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Frequently Asked Questions

What sell-side analysts currently cover shares of NeueHealth?

The following Wall Street sell-side analysts have issued reports on NeueHealth in the last year: Royal Bank of Canada.
View the latest analyst ratings for NEUE.

What is the current price target for NeueHealth?

1 Wall Street analysts have set twelve-month price targets for NeueHealth in the last year. Their average twelve-month price target is $8.00, suggesting a possible upside of 30.9%. Royal Bank of Canada has the highest price target set, predicting NEUE will reach $8.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $8.00 for NeueHealth in the next year.
View the latest price targets for NEUE.

What is the current consensus analyst rating for NeueHealth?

NeueHealth currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NEUE, but not buy more shares or sell existing shares.
View the latest ratings for NEUE.

What other companies compete with NeueHealth?

Other companies that are similar to NeueHealth include Bright Health Group, Zepp Health, Apyx Medical, Genenta Science and AVROBIO. Learn More about companies similar to NeueHealth.

How do I contact NeueHealth's investor relations team?

NeueHealth's physical mailing address is 8000 Norman Center Drive, Suite 900, Minneapolis, MN 55437, United States. The company's listed phone number is 612-238-1321 and its investor relations email address is [email protected]. The official website for NeueHealth is www.brighthealthgroup.com. Learn More about contacing NeueHealth investor relations.